Setting up of a national liver transplant programme for neuroendocrine tumor liver metastases in UK and Ireland: Opportunities for collaborations in clinical study and research

#3579

Introduction: Liver transplantation [LT] for unresectable neuroendocrine tumor liver metastases [NET LM] is one of three new cancer indications in UK and Ireland. Transplant benefit is only proven using the Milan criteria so patient selection needs to be meticulously objective. We have therefore created a national MDT to provide a formal framework, aid patient selection, oversee data collection, monitor performance, provide training and education, deliver equity of access, facilitate research and clinical trials.

Aim(s): To develop national infrastructure for delivering a successful NET LT programme in terms of parameters set out above.

Materials and methods: National MDT formed: Participants from liver transplant / NET Centres identified with expertise in NET management, liver transplantation, pancreatic surgery, GI surgery, imaging, nuclear medicine and nursing. Documentation completed – patient information sheet, programme manuel, patient pathway document, referral proformer, data fields. Infrastructure arranged – MDT room and IT support for combined physical/virtual participation. Administrative support arranged – MDT co-ordinator, NET CNS, liver transplant co-ordinator, data manager.

Conference:

Presenting Author:

Authors: Shah T, Gibbs P, Moore J, Venkataraman H, O'Toole D,

Keywords: liver transplantation, neuroendocrine tumor liver metastasis, neuroendocrine tumor surgery,